• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种清创凝胶在创伤后不愈合伤口治疗中的应用。

A debriding gel in the treatment of post-trauma, non-healing lesions.

作者信息

Hermans Michel He

机构信息

Hermans Medical Consulting Hoorn, The Netherlands.

出版信息

Int J Burns Trauma. 2023 Jun 15;13(3):136-141. eCollection 2023.

PMID:37455802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10349327/
Abstract

BACKGROUND

Topical desiccation agent (TDA) is an acidic species in a gel with a potent hygroscopic action. When in contact with (water in) biofilm and necrosis, rapid desiccation occurs, with the dehydrated tissues typically sloughing off in 1-3 days. This allows for quick granulation tissue formation which is an essential step for healing by secondary intention or as wound bed preparation for grafting.

METHODS

A series of nine non-healing, post-trauma lesions on the lower leg were treated with TDA, followed by treatment of the lesion with vaseline gauze.

RESULTS

The average age of the patients was 77.0 years and the lesions had been in existence for 5.6 months on average. The average size of the lesion was 15.9 cm. Complete granulation of all lesions was reached in an average of 34.1 days while the time to complete reepithelialization averaged, 69.8 days (data from one outlier removed). There were no adverse events.

CONCLUSION

These data suggest TDA treatment is an effective and efficient way to debride lesions, and to prepare them for healing by secondary intention or for grafting.

摘要

背景

局部干燥剂(TDA)是一种凝胶状的酸性物质,具有强大的吸湿作用。当与生物膜和坏死组织中的(水分)接触时,会迅速发生干燥,脱水组织通常在1 - 3天内脱落。这有利于快速形成肉芽组织,这是二期愈合或作为移植创面床准备的关键步骤。

方法

对小腿上一系列9处创伤后不愈合的损伤使用TDA进行治疗,随后用凡士林纱布处理损伤部位。

结果

患者的平均年龄为77.0岁,损伤平均已存在5.6个月。损伤的平均大小为15.9平方厘米。所有损伤平均在34.1天达到完全肉芽形成,而完全重新上皮化的时间平均为69.8天(去除一个异常值的数据)。未发生不良事件。

结论

这些数据表明,TDA治疗是一种有效且高效的清创方法,可为二期愈合或移植准备创面。

相似文献

1
A debriding gel in the treatment of post-trauma, non-healing lesions.一种清创凝胶在创伤后不愈合伤口治疗中的应用。
Int J Burns Trauma. 2023 Jun 15;13(3):136-141. eCollection 2023.
2
A desiccation compound as a biofilm- and necrosis-removing agent: a case series.干燥化合物作为一种生物膜和坏死清除剂:病例系列。
J Wound Care. 2022 Oct 2;31(10):816-822. doi: 10.12968/jowc.2022.31.10.816.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention.清创剂治疗二期愈合手术伤口的临床有效性和成本效益的快速系统评价
Health Technol Assess. 2001;5(14):1-131. doi: 10.3310/hta5140.
4
[A prospective randomized controlled study of the application effect of hydrogel dressings on deep partial-thickness burn wounds after dermabrasion and tangential excision].[水凝胶敷料在削痂及削痂联合切痂后深Ⅱ度烧伤创面应用效果的前瞻性随机对照研究]
Zhonghua Shao Shang Za Zhi. 2021 Nov 20;37(11):1085-1089. doi: 10.3760/cma.j.cn501120-20210419-00133.
5
Biofilm management using monofilament fibre debridement technology: outcomes and clinician and patient satisfaction.使用单丝纤维清创技术进行生物膜管理:结果以及临床医生和患者的满意度。
J Wound Care. 2019 Sep 2;28(9):608-622. doi: 10.12968/jowc.2019.28.9.608.
6
Efficacy and tolerance of calcium alginate versus vaseline gauze dressings in the treatment of diabetic foot lesions.海藻酸钙与凡士林纱布敷料治疗糖尿病足溃疡的疗效及耐受性比较
Diabetes Metab. 2002 Jun;28(3):223-9.
7
Cadaveric allograft as adjunct therapy for nonhealing ulcers.尸体同种异体移植作为难愈合溃疡的辅助治疗方法。
J Foot Ankle Surg. 1999 Mar-Apr;38(2):93-101. doi: 10.1016/s1067-2516(99)80019-2.
8
[Influence of polyester gauze on evaporation capacity and healing of the surface of microskin graft wound after escharectomy].[聚酯纱布对焦痂切除术后微粒皮移植创面蒸发能力及创面愈合的影响]
Zhonghua Yi Xue Za Zhi. 2009 Jan 13;89(2):105-8.
9
Wound care in venous ulcers.静脉性溃疡的伤口护理
Phlebology. 2013 Mar;28 Suppl 1:79-85. doi: 10.1177/0268355513477015.
10
Negative pressure wound therapy using gauze and foam: histological, immunohistochemical and ultrasonography morphological analysis of the granulation tissue and scar tissue. Preliminary report of a clinical study.负压伤口疗法联合纱布和泡沫:肉芽组织和瘢痕组织的组织学、免疫组织化学和超声形态学分析。一项临床研究的初步报告。
Int Wound J. 2011 Aug;8(4):355-64. doi: 10.1111/j.1742-481X.2011.00798.x. Epub 2011 May 12.

本文引用的文献

1
A desiccation compound as a biofilm- and necrosis-removing agent: a case series.干燥化合物作为一种生物膜和坏死清除剂:病例系列。
J Wound Care. 2022 Oct 2;31(10):816-822. doi: 10.12968/jowc.2022.31.10.816.
2
Treatment of Hematomas Using a Synthetic Hybrid-Scale Fiber Matrix.使用合成混合尺度纤维基质治疗血肿。
Cureus. 2022 Jul 1;14(7):e26491. doi: 10.7759/cureus.26491. eCollection 2022 Jul.
3
Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK.Debrichem在英国治疗难愈合下肢静脉溃疡中的成本效益。
J Wound Care. 2022 Jun 2;31(6):480-491. doi: 10.12968/jowc.2022.31.6.480.
4
What does a (general and abdominal) surgeon need to know on plastic surgery?一名(普通外科和腹部外科)外科医生需要了解哪些有关整形手术的知识?
Pol Przegl Chir. 2019 Jun 6;91(5):41-50. doi: 10.5604/01.3001.0013.2365.
5
Skin Changes During Ageing.衰老过程中的皮肤变化。
Subcell Biochem. 2019;91:249-280. doi: 10.1007/978-981-13-3681-2_10.
6
Current health and economic burden of chronic diabetic osteomyelitis.慢性糖尿病性骨髓炎的当前健康和经济负担。
Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):279-286. doi: 10.1080/14737167.2019.1567337. Epub 2019 Jan 21.
7
Pathophysiology of Chronic Venous Disease and Venous Ulcers.慢性静脉疾病和静脉溃疡的病理生理学
Surg Clin North Am. 2018 Apr;98(2):337-347. doi: 10.1016/j.suc.2017.11.002. Epub 2018 Jan 5.
8
[BASIC PRINCIPLES OF SURGICAL TREATMENT OF CHRONIC WOUNDS – SHARP DEBRIDEMENT].[慢性伤口外科治疗的基本原则——锐性清创术]
Acta Med Croatica. 2016;70 Suppl 1:65-8.
9
Skin graft donor site: a procedure for a faster healing.皮肤移植供区:一种促进更快愈合的方法。
Acta Biomed. 2017 Oct 23;88(3):310-314. doi: 10.23750/abm.v88i3.5736.
10
The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data.慢性伤口中生物膜的患病率:已发表数据的系统评价和荟萃分析
J Wound Care. 2017 Jan 2;26(1):20-25. doi: 10.12968/jowc.2017.26.1.20.